FIBROADENOMATIOD HYPERPLASIA: IMAGING APPEARANCES AND PATHOLOGICAL CORRELATION.

Hanson CA, Snover DC, Dehner LP. Fibroadenomatosis _(fibroadenomatoid mastopathy): a benign breast lesion with composite pathologic features. Pathology 1987;19:393-396

Schuerch C, Rosen PP, Hirota T, et al. A pathologic study of benign breast diseases in Tokyo and New York. Cancer 1982;50: 1899-1903

Kovi J, Chu HB, Leffall LD. Sclerosing lobular hyperplasia manifesting as a palpable mass of the breast in young black woman. Hum Pathol 1984;15:336-340

Poulton TB, de Paredes ES, Baldwin M. Sclerosing lobular hyperplasia of the breast: imaging features in 15 cases. AJR 1995;165:291-294

Semb C. Pathologico-anatomical and clinical investigations of fibroadenomatosis cystica mammae and its relationship to other pathological conditions in the mamma, especially cancer. Acta Chir Scand 1928;64 (Suppl 10):1-482

Cole P, Elwood JM, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol 1978;108: 112-120

Nielsen BB. Fibroadenomatoid hyperplasia of the male breast. Am J Surg Pathol 1990;14(8):774-777

Kamal M,Evans AJ,Denley H, Pinder SE, Ellis IO. Fibroadenomatoid hyperplasia: a cause of suspicious microcalcification on mammographic screening. AJR 1998;171: 1331-1334

Brinck V., Fischer V, Kanablowska M., Schauer A., Grabbe E. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography. AJR 1997; 168:1331-1334

Kuhl CK., Micleerek P, Klaschik S, et al. Are signal time course data useful for differential diagnosis of enhancing lesion in dynamic breast MR _ imaging? Radiology 1999;211:101-110

Kuhl CK, Mielcarek P, Klaschik S, Pabos E, Schild H. Are T2 weighted pulse sequences helpful to assist differential diagnosis of enhancing lesions in dynamic breast MRI? J Magn. Reson Imaging 1999; 9:187-196

Feig SA. Principles and Practice of Breast Imaging. Seminar in Breast Disease 1999; 1:3-16